Stay updated with the latest australian-securities-exchange news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on australian-securities-exchange topics.
LONDON - South32 (OTC:SOUHY) Limited (ASX / LSE / JSE: S32; ADR: SOUHY), the globally diversified mining and metals company, announced the appointment of Stephen Pearce and Mandla Msimang as independent Non-Executive Directors to its Board, effective from February 1, 2025. Both Pearce and Msimang will seek election by shareholders at the company's 2025 Annual General Meeting. Stephen Pearce brings over two decades of directorship experience and is currently serving on the board of BAE Systems ( ...Read More >
LONDON - Bigblu Broadband plc (AIM: BBB.L), a significant provider of super-fast and ultra-fast alternative broadband services, has conditionally agreed to sell its Australian subsidiary, SkyMesh Pty Ltd, to SKM Telecommunication Services Pty Ltd for up to AUD$50.20 million (approximately £25.67 million). SKM Telecommunication, formed by Salter Brothers Asset Management for the acquisition, will pay the headline price in a combination of cash, shares, and deferred cash considerations. The sale ...Read More >
Bangkok, Shares were mixed on Thursday in Asia after stocks on Wall Street retreated, weighed down by losses for technology shares. Tokyo's Nikkei 225 index gained 0.7 per cent to 38,400.00 and Australia's S and P/ASX 200 advanced 0.8 per cent to 8,473.30. South Korea's Kospi was unchanged at 2,503.01 after the central bank cut its benchmark interest rate to relieve pressure on the economy. The Bank of Korea cut its key rate by a quarter percentage point to 3 per cent and lowered its outlook ...Read More >
MELBOURNE, Australia, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces it will expand its theranostic pipeline with new assets targeting Fibroblast Activation Protein (FAP), one of the most promising pan-cancer targets in nuclear medicine. Telix's development program will initially focus on the treatment of bladder cancer, rounding out its urology franchise, which includes late-stage therapeutic programs for kidney and pr ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.